Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA12 - Novel and Combination Strategies for SCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      Session Moderator

      16:52 - 17:00  |  Presenter: Alessandra Curioni-Fontecedro

      • Abstract

      Loading...

    • +

      Session Moderator

      16:52 - 17:00  |  Presenter: Kostas Syrigos

      • Abstract

      Loading...

    • +

      OA12.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Alessandra Curioni-Fontecedro

      • Abstract

      Loading...

    • +

      OA12.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Kostas Syrigos

      • Abstract

      Loading...

    • +

      OA12.03 - Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

      16:02 - 16:12  |  Presenter: Jonathan Goldman

      • Abstract

      Loading...

    • +

      OA12.04 - Efficacy of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer after Chemo-Immunotherapy: A Phase 2 Trial.

      16:12 - 16:22  |  Presenter: Dwight H Owen

      • Abstract

      Loading...

    • +

      OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

      16:22 - 16:32  |  Presenter: Hossein Borghaei

      • Abstract

      Loading...

    • +

      OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results

      16:32 - 16:42  |  Presenter: Charles M Rudin

      • Abstract

      Loading...

    • +

      OA12.07 - Discussant

      16:42 - 16:52  |  Presenter: Virginie Westeel

      • Abstract

      Loading...

    • +

      OA12.08 - Live Q&A

      16:52 - 17:00

      • Abstract

      Loading...